180 Life Sciences (ATNF) Revenue & Revenue Breakdown
180 Life Sciences Revenue Highlights
00
180 Life Sciences Revenue by Period
180 Life Sciences Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | - | 100.00% |
2022-12-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2020-12-31 | - | 100.00% |
2019-12-31 | - | 100.00% |
2018-12-31 | - | 100.00% |
2017-12-31 | - | - |
180 Life Sciences Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-09-30 | - | 100.00% |
2024-06-30 | - | 100.00% |
2024-03-31 | - | -100.00% |
2023-12-31 | $166.03K | 100.00% |
2023-09-30 | - | 100.00% |
2023-06-30 | - | 100.00% |
2023-03-31 | - | 100.00% |
2022-12-31 | - | 100.00% |
2022-09-30 | - | 100.00% |
2022-06-30 | - | 100.00% |
2022-03-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2021-09-30 | - | 100.00% |
2021-06-30 | - | 100.00% |
2021-03-31 | - | 100.00% |
2020-12-31 | - | 100.00% |
2020-09-30 | - | 100.00% |
2020-06-30 | - | 100.00% |
2020-03-31 | - | 100.00% |
2019-12-31 | - | 100.00% |
2019-09-30 | - | 100.00% |
2019-06-30 | - | 100.00% |
2019-03-31 | - | 100.00% |
2018-12-31 | - | 100.00% |
2018-09-30 | - | 100.00% |
2018-06-30 | - | 100.00% |
2018-03-31 | - | 100.00% |
2017-09-30 | - | 100.00% |
2017-06-30 | - | - |
180 Life Sciences Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
PALI | Palisade Bio | $250.00K | - |
SONN | Sonnet BioTherapeutics | $147.81K | - |
CNSP | CNS Pharmaceuticals | - | - |
CYTO | Altamira Therapeutics | - | $52.73K |
ZURA | Zura Bio | - | - |
ATNF | 180 Life Sciences | - | - |
PHIO | Phio Pharmaceuticals | - | - |
ZVSA | ZyVersa Therapeutics | - | - |
IMMX | Immix Biopharma | - | - |
ENVB | Enveric Biosciences | - | - |
EFTR | eFFECTOR Therapeutics | - | - |
CDIO | Cardio Diagnostics | - | $6.58K |